Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
ALI HEALTH Joins Yiling Pharmaceutical to Build Digital Disease Center for Allergic Rhinitis
Recommend 24 Positive 20 Negative 10 |
||||
|
||||
|
ALI HEALTH (00241.HK) and Yiling Pharmaceutical (002603.SZ) have announced a strategic partnership, under which both parties will not only engage in deep collaboration in areas like patient education and chronic disease management, but they will also build and operate a digital disease center for allergic rhinitis. It is understood that the digital disease center will integrate ALI HEALTH's digital platform capabilities with Yiling Pharmaceutical's experience in traditional Chinese medicine R&D, constructing a health management cycle that covers disease awareness, medical education, diagnostic recommendations, standardized medication guidance, and long-term follow-up. AAStocks Financial News |
||||
Copied to Clipboard
 |
||||
